Home > Healthcare > Drug Device Combination > Drug Filled Devices > Antidiabetics Market

Antidiabetics Market Size

Report ID: GMI504
Published Date: Jun 2020
Report Format: PDF

Download Free Sample

Antidiabetics Market Size

Antidiabetics Market size was USD 65.5 billion in 2019 and will grow at a CAGR of 10.7% from 2020 to 2026.

Increasing prevalence of diabetes across the globe will stimulate the market potential for antidiabetics drugs during forecast period. Need for effective treatment with low side effects will result into increasing R&D spending by pharmaceutical firms for drug development. Thus, escalating demand and adoption of antidiabetic drugs in developing as well as developed nations will boost the market growth in the upcoming period.

Antidiabetics Market Report Attributes
Report Attribute	Details
Base Year:	2019
Antidiabetics Market Size in 2019:	USD 66.7 Billion
Forecast Period:	2020 to 2026
Forecast Period 2020 to 2026 CAGR:	10.7%
2026 Value Projection:	USD 135.9 Billion
Historical Data for:	2015 to 2019
No. of Pages:	202
Tables, Charts & Figures:	276
Segments covered:	Product, Patient population, Route of Administration and Region
Growth Drivers:	Strong product pipeline of antidiabetics Globally rising prevalence of diabetes Increasing prevalence of lifestyle induced disorders such as obesity Growing adoption of oral antidiabetic drugs Rising spending on R&D for innovative drugs
Pitfalls & Challenges:	Prohibitive cost of insulin Safety issues pertaining to some diabetic drugs

Learn more about the key segments shaping this market

Download Free Sample

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The market size of antidiabetics exceeded USD 65.5 million in 2019.

The industry share of antidiabetics is expected to witness growth at over 10.7% CAGR from 2020 to 2026.

U.S. market will grow at 10.3% CAGR through 2026, says this GMI report.

Insulin market constituted significant industry share in 2019 and is expected to proceed at 12.4% CAGR up to 2026.

Insulin pump segment is forecast to progress at over 11% CAGR during the forecast years.

Some of the prominent business players operating in the antidiabetics industry include AstraZeneca, Novartis AG, Johnson & Johnson, Merck & Co. Inc., Pfizer and Sanofi.